| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.22 | 6e-09 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-08 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |